KPC PharmaceuticalsInc's (SHSE:600422) Investors Will Be Pleased With Their Respectable 86% Return Over the Last Five Years

Simply Wall StMar 24 19:19 ET

GF Securities Starts KPC Pharmaceuticals at Buy With 20.80 Yuan Price Target

MT NewswiresMar 17 05:00 ET · Ratings

GTJA: Continuous iteration of anti-tumor therapies, domestic new drugs welcome breakthroughs.

GTJA focuses on products with significant differentiation advantages and leading companies in innovative segments.

Zhitong FinanceMar 16 21:18 ET

KPC Pharmaceuticals' 2024 Profit Rises 20%

MT NewswiresMar 12 03:12 ET

KPC Group: KPC 2024 Annual Report

SZSIMar 11 12:00 ET · Announcements

KPC Group: Summary of the 2024 Annual Report of KPC

SZSIMar 11 12:00 ET · Announcements